Sign in Register

Drug class

Amyotrophic Lateral Sclerosis Agents - Anti-glutamatergics

Amyotrophic Lateral Sclerosis Agents - Anti-glutamatergics is a compendial and clinical drug classification comprising neuroprotective medications specifically indicated to slow disease progression in amyotrophic lateral sclerosis. Read more about Amyotrophic Lateral Sclerosis Agents - Anti-glutamatergics

9 drugs in this class 8 manufacturers

Advertisement

Related classes & indications

Antipsychotics, AtypicalCNS, pain & psychiatry · 296 prescription drugs Antidepressant Serotonin-Norepinephrine Reuptake Inh.(SNRIs)CNS, pain & psychiatry · 127 prescription drugs Amyotrophic Lateral SclerosisTop indication · 23 prescription drugs

Drugs in Amyotrophic Lateral Sclerosis Agents - Anti-glutamatergics

Showing 1–9 of 9 drugs

RILUZOLE

AMYOTROPHIC LATERAL SCLEROSIS AGENTS - ANTI-GLUTAMATERGICS · AMYOTROPHIC LATERAL SCLEROSIS
APOTEX CORP

RILUZOLE

AMYOTROPHIC LATERAL SCLEROSIS AGENTS - ANTI-GLUTAMATERGICS · AMYOTROPHIC LATERAL SCLEROSIS
SUN PHARMACEUTI

RILUZOLE

AMYOTROPHIC LATERAL SCLEROSIS AGENTS - ANTI-GLUTAMATERGICS · AMYOTROPHIC LATERAL SCLEROSIS
ASCEND LABORATO

TIGLUTIK (riluzole)

AMYOTROPHIC LATERAL SCLEROSIS AGENTS - ANTI-GLUTAMATERGICS · AMYOTROPHIC LATERAL SCLEROSIS
ITF PHARMA-EDW

EXSERVAN (riluzole)

AMYOTROPHIC LATERAL SCLEROSIS AGENTS - ANTI-GLUTAMATERGICS · AMYOTROPHIC LATERAL SCLEROSIS
MITSUBISHI TANA

TEGLUTIK (riluzole)

AMYOTROPHIC LATERAL SCLEROSIS AGENTS - ANTI-GLUTAMATERGICS · AMYOTROPHIC LATERAL SCLEROSIS
EDW PHARMA

RILUZOLE

AMYOTROPHIC LATERAL SCLEROSIS AGENTS - ANTI-GLUTAMATERGICS · AMYOTROPHIC LATERAL SCLEROSIS
AVKARE

RILUZOLE

AMYOTROPHIC LATERAL SCLEROSIS AGENTS - ANTI-GLUTAMATERGICS · AMYOTROPHIC LATERAL SCLEROSIS
QUINN PHARMACEU

TEGLUTIK (riluzole)

AMYOTROPHIC LATERAL SCLEROSIS AGENTS - ANTI-GLUTAMATERGICS · AMYOTROPHIC LATERAL SCLEROSIS
ITF PHARMA-EDW
Filter & compare in the drug finder → Opens the drug finder with Amyotrophic Lateral Sclerosis Agents - Anti-glutamatergics preselected. Add indication or manufacturer filters there.

About Amyotrophic Lateral Sclerosis Agents - Anti-glutamatergics.

Amyotrophic Lateral Sclerosis Agents - Anti-glutamatergics is a compendial and clinical drug classification comprising neuroprotective medications specifically indicated to slow disease progression in amyotrophic lateral sclerosis.

The principal agent in this class, riluzole, exerts anti-glutamatergic activity by inhibiting presynaptic glutamate release, inactivating voltage-dependent sodium channels, and modulating post-synaptic glutamate receptor signaling to attenuate glutamate-mediated excitotoxicity and motor neuron injury.

Therapeutically, these agents are utilized to extend tracheostomy-free survival and delay ventilatory dependence in individuals diagnosed with amyotrophic lateral sclerosis.